Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
NCT01602939
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Systemic Mastocytosis
Interventions
DRUG:
Cladribine and pegylated interpheron alpha-2a
Sponsor
Hospital Virgen de la Salud